Ashland Inc.
NYSE:ASHChemicals - Specialty
+$2.75 today
- Market cap
- $3.50B
- Beta
- 0.43
- P/E (TTM)
- -4.4
- EPS (TTM)
- -$15.42
- Dividend yield
- 2.48%
Volume 0.82M
Average 0.92M
ASH Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Ashland Inc.NYSE: ASH
Research & Development · Q3 FY2026 · quarter ended Jun 2026
Research & development growth accelerates
Q3 FY2026 research & development of $15M rose 15.4% year over year, ahead of the +3.8% change in trailing-twelve-month research & development. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at -0.6% a year.
Context
- Research & development amounted to 3.0% of revenue in FY2025, up 0.4 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +15.4% holds above the trailing-twelve-month pace of +3.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 54M USD
- Year-over-year change
- -1.8%
- 4-year CAGR
- +1.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 54M | -1.8% |
| FY2024 | 2024-09-30 | 55M | +7.8% |
| FY2023 | 2023-09-30 | 51M | -7.3% |
| FY2022 | 2022-09-30 | 55M | +10.0% |
| FY2021 | 2021-09-30 | 50M | — |
Research & Development vs competitors
How ASH compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +3.8% is the 3rd highest of 7, against a peer median of -1.8%.
- Research & development amounts to 3.0% of revenue for ASH, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $106M USD | -3.6% | -2.9% | 1.8% | |
| LTM Mar 2026 | R$60.87M BRL | +27.5% | +12.1% | 0.1% | |
| LTM Jun 2026 | $55M USD | +3.8% | -0.6% | 3.0% | |
| LTM Jun 2026 | $52.1M USD | +4.0% | +9.6% | 2.8% | |
| LTM Apr 2026 | $23.2M USD | +0.0% | +3.9% | 1.1% | |
| LTM Sep 2026 | $20.2M USD | -32.2% | -2.1% | 1.8% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | CA$0 CAD | — | — | — | |
| LTM Aug 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ASH) | — | -1.8% | +3.9% | 0.1% | |
Competitors are the stored peer set for ASH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 2.11B | 2.39B | 2.19B | 2.11B | 1.82B |
| Cost of Revenue | 1.44B | 1.56B | 1.52B | 1.5B | 1.28B |
| Gross Profit | 670M | 830M | 668M | 618M | 549M |
| Gross Margin | 31.7% | 34.7% | 30.5% | 29.2% | 30.1% |
| Research & Development | 50M | 55M | 51M | 55M | 54M |
| Selling, General & Admin | 358M | 393M | 365M | 404M | 345M |
| Operating Expenses | 478M | 497M | 496M | 644M | 1.32B |
| Depreciation & Amortization | 244M | 241M | 243M | 274M | 237M |
| EBITDA | 448M | 509M | 457M | 303M | (509M) |
| EBITDA Margin | 21.2% | 21.3% | 20.9% | 14.3% | -27.9% |
| Operating Income | 192M | 333M | 172M | (26M) | (775M) |
| Operating Margin | 9.1% | 13.9% | 7.9% | -1.2% | -42.5% |
| Interest Income | 1M | 4M | 12M | 10M | 5M |
| Interest Expense | 73M | 66M | 57M | 53M | 63M |
| Other Income / Expenses | (57M) | (127M) | (12M) | 2M | (34M) |
| Income Before Tax | 135M | 206M | 160M | (24M) | (809M) |
| Pre-Tax Margin | 6.4% | 8.6% | 7.3% | -1.1% | -44.4% |
| Income Tax Expense | (38M) | 25M | (8M) | (223M) | 13M |
| Net Income | 220M | 927M | 178M | 169M | (845M) |
| Net Margin | 10.4% | 38.8% | 8.1% | 8.0% | -46.3% |
| EPS (Basic) | 3.66 | 17.17 | 3.36 | 3.45 | (18.37) |
| EPS (Diluted) | 3.66 | 16.41 | 3.31 | 3.38 | (18.37) |
| Weighted Avg Shares | 61M | 54M | 53M | 49M | 46M |
| Weighted Avg Shares (Diluted) | 61M | 56M | 54M | 50M | 46M |
Ashland Inc.
NYSE:ASH
Intrinsic Alpha fair value
Locked
Current Price
$76.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.